课题基金 / 基金详情

Addition of exogenous Tat during early infection to inhibit the establishment of latency

Addition of exogenous Tat during early infection to inhibit the establishment of latency
在感染早期添加外源Tat以抑制潜伏期的建立
批准号：
206107
负责人：
Donahue Daniel A
金额：
$7.65万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2012-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=206107&lang=en
关键词：
Aids Antiretroviral Drugs Cell Culture Flow Cytometry Gfp Hiv Latency Novel Approach Real-Time Pcr Tat

项目摘要

项目成果

Donahue Daniel A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is currently no vaccine against HIV, the virus that causes AIDS. Although treatment of HIV infection is possible using antiretroviral drugs, it is not currently possible to completely remove HIV from an individual after he/she becomes infected. One
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of cytokine deregulation caused by HIV-1 vs HIV-2 infection of antigen presenting cells on CD4 T-cell polarization and function
海外基金